Literature DB >> 28174206

Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma.

Chenchen Yang1,2, Shutao Zheng1,2, Tao Liu1,2, Qing Liu1,2, Fang Dai1,2, Jian Zhou1,2, Yumei Chen1,2, Ilyar Sheyhidin2, Xiaomei Lu3,2.   

Abstract

Numerous studies have reported that the role played by miR-26a in cancer is controversial, but whether miR-26a regulates metadherin (MTDH) expression in esophageal squamous cell carcinoma (ESCC) is unclear. We performed this study to investigate the clinical relevance of miR-26a expression in ESCC. miR-26a was detected by using the in situ hybridization method. To functionally analyze the role of miR-26a in ESCC cell lines in vitro, KYSE-450 and Eca109 cells were employed, whose endogenous miR-26a was artificially down- or up-regulated, respectively, by using lentiviral-based transfection. There was significant association between miR-26a expression and clinical stage (P = 0.049), lymph node metastasis (P = 0.023), tumor volume (P = 0.003), and poor overall prognosis (P = 0.026). miR-26a was able to suppress proliferation and migration of ESCC cells in vitro Moreover, we have confirmed that miR-26a can negatively regulate MTDH in ESCC cells by using luciferase reporter assay. In addition, to investigate the role miR-26a plays in cell proliferation, we nude mice were xenografted with ESCC cells whose miR-26a was stably down- and up-regulated. Together, our results show that miR-26a is capable of suppressing the proliferation and migration of ESCC cells via negative regulation of MTDH. Moreover, miR-26a expression was clinically relevant in cancer progression and poor prognosis, which supports the idea that miR-26a acts as a tumor suppressor in ESCC.-Yang, C., Zheng, S., Liu, T., Liu, Q., Dai, F., Zhou, J., Chen, Y., Sheyhidin, I., Lu, X. Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma. © FASEB.

Entities:  

Keywords:  ESCC; malignant phenotype; regulatory mechanism

Mesh:

Substances:

Year:  2017        PMID: 28174206     DOI: 10.1096/fj.201601237

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  TGF-β1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT.

Authors:  Qing Liu; Shutao Zheng; Yumei Chen; Tao Liu; Xiujuan Han; Xiao Zhang; Tongxue Shen; Xiaomei Lu
Journal:  J Cancer       Date:  2020-10-04       Impact factor: 4.207

2.  Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis.

Authors:  Xing Zeng; Zhiquan Hu; Xinwen Ke; Huake Tang; Bolin Wu; Xian Wei; Zheng Liu
Journal:  Cell Cycle       Date:  2017-09-07       Impact factor: 4.534

3.  Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.

Authors:  Song Gao; Zhi-Ying Zhao; Zhen-Yong Zhang; Yue Zhang; Rong Wu
Journal:  Clin Transl Gastroenterol       Date:  2018-11-13       Impact factor: 4.488

4.  Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).

Authors:  Yi-Fang Lu; Jia-Rui Yu; Zhao Yang; Guan-Xia Zhu; Peng Gao; Huan Wang; Si-Yuan Chen; Jie Zhang; Mei-Yue Liu; Yi Niu; Xiao-Mei Wei; Wei Wang; Feng-Jin Ye; Li-Xin Zhang; Yue Zhao; Guo-Gui Sun
Journal:  J Exp Clin Cancer Res       Date:  2018-12-04

5.  PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.

Authors:  Yue Zhao; Qijue Lu; Chunguang Li; Xinyu Wang; Long Jiang; Lei Huang; Chao Wang; Hezhong Chen
Journal:  Cell Death Dis       Date:  2019-05-01       Impact factor: 8.469

6.  LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.

Authors:  Chunyong Han; Yiwei Fu; Ni Zeng; Jian Yin; Qian Li
Journal:  Aging (Albany NY)       Date:  2020-02-17       Impact factor: 5.682

7.  MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH.

Authors:  Yike Wang; Lifeng Dong; Fang Wan; Fangfang Chen; Dianlei Liu; Deqin Chen; Jingpei Long
Journal:  Cell Death Dis       Date:  2021-09-22       Impact factor: 8.469

Review 8.  Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Authors:  Arsinoe C Thomaidou; Panagiota Batsaki; Maria Adamaki; Maria Goulielmaki; Constantin N Baxevanis; Vassilis Zoumpourlis; Sotirios P Fortis
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

9.  Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The Cancer Genome Atlas database.

Authors:  Xin Zhao; Jian Dou; Jinglin Cao; Yang Wang; Qingjun Gao; Qiang Zeng; Wenpeng Liu; Baowang Liu; Ziqiang Cui; Liang Teng; Junhong Zhang; Caiyan Zhao
Journal:  Oncol Rep       Date:  2020-03-19       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.